n'ókè
Wired
Enwere ike iji protein CRISPR jiri usoro na-abawanye RNA iji chọpụta mkpụrụ ndụ kansa
n'ókè
The New England Journal of Medicine
n'ókè
Futurism
Russian biologist Denis Rebrikov says he's found five couples who want him to use CRISPR to ensure their offspring do not inherit their deafness.
n'ókè
MIT Technology Review
Can the powerful gene-editing tool CRISPR help cure diseases? Drug companies are racing to find out. A recently announced $300 million joint venture between Bayer AG and startup CRISPR Therapeutics—to develop new drugs for blood disorders, blindness, and congenital heart disease—is just the latest indication that the pharmaceutical industry is eager to find and develop…
n'ókè
Akụkọ ihe mere eme nke Cornell
Onye na-eme nchọpụta Cornell, bụ onye ndu n'ịzụlite ụdị ọhụrụ nke usoro nhazi CRISPR nke mkpụrụ ndụ ihe nketa, na ndị ọrụ ibe ejirila usoro ọhụrụ ahụ mee ihe maka oge mbụ na sel mmadụ - nnukwu ọganihu n'ọhịa.
n'ókè
Nature
Ọmụmụ ihe atọ na-egosi nnukwu ihichapụ DNA na nhazigharị na-eme ka nchegbu nchekwa dị elu gbasara ndezi genome eketa. Ọmụmụ ihe atọ na-egosi nnukwu ihichapụ DNA na nhazigharị na-eme ka nchegbu nchekwa dị elu gbasara ndezi genome eketa.
n'ókè
Anụ
n'ókè
Wired
Tessera Therapeutics na-emepụta klas ọhụrụ nke ndị na-edezi mkpụrụ ndụ ihe nketa nwere ike itinye kpọmkwem DNA ogologo ogologo - ihe Crispr enweghị ike ime.
n'ókè
New Scientist
Two people with beta thalassaemia and one with sickle cell disease no longer need blood transfusions after their blood stem cells were gene edited and put back in their bodies
n'ókè
Atlas ọhụrụ
An incredible new breakthrough from scientists at ETH Zurich has, for the first time, demonstrated a new CRISPR method that can modify dozens of genes simultaneously, allowing for more large-scale cell reprogramming.
n'ókè
Egwú Singularity
China na-ahụ mgbawa na ọmụmụ anụmanụ nke dabeere na CRISPR ma nabata teknụzụ na-edezi mkpụrụ ndụ ihe nketa na ịnụ ọkụ n'obi enweghị atụ.
n'ókè
Nature
Parasitic genetic elements called transposons carry CRISPR machinery that is normally used against them by bacterial cells. This paradox has now been explained, with implications for gene-therapy research. RNA-guided transposition of DNA.
n'ókè
Nature
Sistemụ CRISPR-Cas nke a na-emebu na-edobe iguzosi ike n'ezi ihe nke genomic site n'ịkwado ntuziaka RNA maka nbibi dabere na nuclease nke ihe mkpụrụ ndụ ihe nketa mkpanaka, gụnyere plasmids na nje. N'ebe a, anyị na-akọwa ngbanwe pụtara ìhè nke ihe atụ a, nke nje nje Tn7-dị ka transposons ejikọtala sistemu CRISPR-Cas na-adịghị erubere ya iji mee ka njikọ RNA na-eduzi nke mkpụrụ ndụ ihe nketa mobile.
n'ókè
Egwú Singularity
Isi ihe abụghị ịkpali egwu ọha na eze maka ngwá ọrụ; kama, ọ bụ ileba anya n'ihu n'ihe egwu nwere ike ịchọta ma chọta ọgwụgwọ mgbochi ma ọ bụ ihe mgbochi.
n'ókè
Nature
The gene-editing system could target a broad swathe of the genome with the help of versatile enzymes. The gene-editing system could target a broad swathe of the genome with the help of versatile enzymes.
n'ókè
TechCrunch
CRISPR, the revolutionary ability to snip out and alter genes with scissor-like precision, has exploded in popularity over the last few years and is generally seen as the standalone wizard of modern gene-editing. However, it’s not a perfect system, sometimes cutting at the wrong place, not working as intended and leaving scientists scratching their heads. […]
n'ókè
CNN
n'ókè
a16z
News and trends covered this week -- all about the latest policy and in practice implication for CRISPR -- include:
* California law requiring labels for self-editing kits (that don't exist yet)
* Alliance (including 13 of the most active companies in gene editing for therapeutics) statement agains…
* California law requiring labels for self-editing kits (that don't exist yet)
* Alliance (including 13 of the most active companies in gene editing for therapeutics) statement agains…
n'ókè
AAA
New ability gives biologists tool to rework bacterial genomes in many ways
n'ókè
Ụlọ oriri na ọṅụṅụ Med
The strategy described in this study could, in principle, be broadly adapted to CAR T-cells development to circumvent some of the possible hurdle of CAR T-cell manufacturing. This system essentially creates a CAR T-cell with an integrated functional rheostat.
n'ókè
Wired
The overuse of antibiotics is brewing disaster for humanity.
n'ókè
Nature
Usoro nhọrọ nke nje bacteria na ọnụ ọgụgụ microbial dị mgbagwoju anya bụ isi ihe na-achịkwa nje bacteria. Enwere ike ịhazi nucleases CRISPR iji gbuo nje bacteria, mana chọrọ usoro nnyefe nke ọma na nke sara mbara ka ọ dị irè. N'ebe a, na-eji Escherichia coli na Salmonella enterica co-culture usoro, anyị na-egosi na plasmids dabeere na IncP RK2 conjugative usoro nwere ike iji dị ka de.
n'ókè
New Scientist
Ndezi mkpụrụ ndụ CRISPR nwere ike ịtụgharị mkpụrụ ndụ abụba ọcha ka ọ bụrụ abụba aja aja nke na-ere ike, usoro na-ebelata oke oke na oke oke yana enwere ike iji gwọọ nsogbu ndị metụtara oke ibu.
n'ókè
Wired
Ndị ọkà mmụta sayensị Stanford na-enyocha ma enwere ike iji teknụzụ na-edezi mkpụrụ ndụ ihe nketa alụso ọrịa ọgụ ọgụ. Mana ka ọ dị ugbu a, ha nwere naanị otu mpempe egwuregwu ka ukwuu.
n'ókè
Na nkenke - Na mkpokọta
Designer babies, the end of diseases, genetically modified humans that never age. Outrageous things that used to be science fiction are suddenly becoming rea...
n'ókè
Sayensị Insiders
Carl Zimmer, a science journalist, explains how the revolutionary new genome-editing tool CRISPR works.Zimmer is a columnist for The New York Times and the a...
n'ókè
Akwụkwọ Nkeji Abụọ
❤️ Pick up cool perks on our Patreon page: https://www.patreon.com/TwoMinutePapers My talk and the full panel discussion at the NATO conference (I start at a...
n'ókè
Npr
This could be a crucial year for the powerful gene-editing technique CRISPR as researchers start testing it in patients to treat diseases such as cancer, blindness and sickle cell disease.
n'ókè
Netiwoloji Teknụzụ
Megatrends bụ usoro dị oke egwu, ndị na-amị mkpụrụ ma nabata ọtụtụ ahịa na mmepe teknụzụ. Usoro ndị a adịlarị n'ụwa anyị taa mana ọ ga-adị mkpa karịa n'afọ ndị na-abịa. N'ebe a, anyị na-akọwapụta megatrends teknụzụ atọ nwere ike ịba uru maka ọdịnihu anyị.
